Global Atrial Fibrillation Device Market to Grow by Almost 10% Through 2013
* Reuters is not responsible for the content in this press release.
Electrophysiology treatment for atrial fibrillation expanding market values,
according to Millennium Research Group
WALTHAM, Mass., Nov. 2 /PRNewswire/ -- According to Millennium Research Group
(MRG), the global authority on medical technology market intelligence, the
atrial fibrillation device market will grow by almost 10% through 2013 in the
US, Europe, and Japan. MRG's Global Markets for Atrial Fibrillation Devices
2009 report finds that many patients will be treated with electrophysiology
technology and related devices as positive clinical results supporting their
use emerges.
Atrial fibrillation, recognized as a significant risk factor for cardiac
morbidity and mortality, causes an estimated 15% of all strokes and will
remain an important focus for physicians as prevalence of the disease rises.
Pharmacotherapy is the primary method of atrial fibrillation management;
medical devices are usually reserved for patients who do not respond to drug
treatment. However, evidence is growing that for some patients
nonpharmacological interventions offer a viable alternative to drugs. Of the
devices included in the report, electrophysiology ablation technologies will
exhibit the strongest expansion, forecast to exhibit over 24% annual growth
over the next five years. The minimally invasive nature of the procedures, as
well as their potential to cure atrial fibrillation rather than just manage
the symptoms, will fuel this growth. Continued improvements made to
electrophysiology technology and growing physician familiarity with the
associated procedural techniques will further drive adoption of this treatment
through 2013.
"Globally, we've seen the development of a number of advanced devices that
deliver more effective treatment of atrial fibrillation," says Dan Whalen,
Analyst at MRG. "New electrophysiology catheters in particular have allowed
physicians to target the unique physiological demands of atrial fibrillation
and will drive procedural growth through 2013 as a result."
MRG's new report, Global Markets for Atrial Fibrillation Devices 2009,
provides important insight into the trends that will fuel product use and
market growth of atrial fibrillation treatment devices through 2013.
Additionally, the report provides full breakdowns of procedures, sales, and
prices of electrophysiology catheters, surgical ablation catheters, and
cardiac rhythm management devices. This report includes five-year forecasts,
up-to-date country-level market shares, and in-depth qualitative insights.
Webinar
Members of the media are welcome to attend our upcoming webinar entitled
Devices vs. Drugs: Will Medical Devices Eat Away at Drug Revenues in the
Atrial Fibrillation Market?
This webinar will be held on Tuesday, November 24, 2009 at 11 a.m. U.S.
Eastern Time. For more information, please contact Amy Krohn at 416-364-7776
ext. 101 or by email at akrohn@mrg.net.
About Millennium Research Group
Millennium Research Group (www.MRG.net), a Decision Resources, Inc. company
(www.DecisionResourcesInc.com), is the global authority on medical technology
market intelligence and the leading provider of strategic information to the
health care sector. The company provides specialized industry expertise
through multiclient market research, ongoing Marketrack(TM) projects, customer
loyalty tracking, facility-level procedure forecasting, and customized
solutions.
About Decision Resources, Inc.
Decision Resources, Inc. is a cohesive portfolio of companies that offers
best-in-class, high-value information, and insights on important sectors of
the health care industry. Clients rely on this analysis and data to make
informed decisions. Please visit Decision Resources, Inc. at
www.DecisionResourcesInc.com.
All company, brand, or product names contained in this document may be
trademarks or registered trademarks of their respective holders.
For more information, contact:
Amy Krohn
Millennium Research Group
416-364-7776 x101
akrohn@mrg.net
Elizabeth Marshall
Decision Resources Inc.
781-296-2563
emarshall@dresources.com
SOURCE Millennium Research Group
Amy Krohn of Millennium Research Group, +1-416-364-7776 ext. 101,
akrohn@mrg.net; or Elizabeth Marshall of Decision Resources Inc.,
+1-781-296-2563, emarshall@dresources.com
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.



Follow Reuters